1-4 of 4
E.J. Shpall
Close
Sort by
Journal Articles

A Dose and Schedule Finding Study of Maintenance Therapy with Low-Dose 5-Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High-Risk AML or MDS.

Marcos de Lima, L. Padua, S. Giralt, C. Hosing, K. Komanduri, M. Qazilbash, E.J. Shpall, P. Thall, S. Qureshi, G. McCormick, W. Tong, U. Popat, A. Soriano, R. Champlin, G. Garcia-Manero
Journal: Blood
Blood (2007) 110 (11): 3012.
https://doi.org/10.1182/blood.V110.11.3012.3012
Published: 2007
Journal Articles

Randomized Study of Double Cord Blood Transplantation (CBT) with Versus without Ex-Vivo Expansion (EXP).

Marcos de Lima, J. McMannis, K. Komanduri, L. Worth, S. Karandish, R. Jones, S. Giralt, L. Cooper, L. Padua, P. Patah, D. Petropoulos, P. Thall, W. Zhang, W. Qiao, S. Robinson, S. Qureshi, I. Khouri, C. Hosing, A. Alousi, G. Rondon, B.S. Andersson, R. Champlin, E.J. Shpall
Journal: Blood
Blood (2007) 110 (11): 2014.
https://doi.org/10.1182/blood.V110.11.2014.2014
Published: 2007
Journal Articles

Long-Term Follow-Up of IV Busulfan (Bu) with Fludarabine (Flu) vs IV Bu with Cyclophosphamide (Cy) as Pre (Allogeneic) Transplant Conditioning Therapy for AML/MDS.

Marcos De Lima, X. Wang, P.F. Thall, D. Couriel, R.B. Jones, E.J. Shpall, U. Popat, S. Giralt, M. Korbling, R. Champlin, B.S. Andersson
Journal: Blood
Blood (2006) 108 (11): 322.
https://doi.org/10.1182/blood.V108.11.322.322
Published: 2006
Journal Articles

Peripheral Blood Progenitor Cell Mobilization Using Stem Cell Factor in Combination With Filgrastim in Breast Cancer Patients

J.A. Glaspy, E.J. Shpall, C.F. LeMaistre, R.A. Briddell, D.M. Menchaca, S.A. Turner, M. Lill, L. Chap, R. Jones, M.D. Wiers, W.P. Sheridan, I.K. McNiece
Journal: Blood
Blood (1997) 90 (8): 2939–2951.
https://doi.org/10.1182/blood.V90.8.2939
Published: 1997